abstract |
The present invention relates to RNAi agents, for example double-stranded RNA (dsRNA) agents, which target the AGT gene. The invention also relates to methods of using such RNAi agents to inhibit the expression of an AGT gene and to methods of preventing and treating a disorder associated with AGT, for example, high blood pressure. |